BrightSpring Health Services, Inc. Common Stock (BTSG) fair value: what the stock is really worth
We calculate from audited financials what BrightSpring Health Services, Inc. Common Stock is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch BrightSpring Health Services, Inc. Common Stock for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 18, 2026.
How to read this chart
32‑month range $8.23 – $72.91 · fair‑value band $9.88 – $28.82 · the $56.78 price screens above the $22.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 18, 2026.
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services.
Show more
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
Stock analysis
BrightSpring Health Services, Inc. Common Stock (BTSG) currently trades at $56.78, while our model-based Fair Value estimate is $22.16, implying the stock looks roughly 156.2% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $32.46 per share, and 0 of the 24 models we run sit above the $56.78 price.
Bear case: the Asset-Based group reads lowest at $6.40, and 24 of the 24 models stay below the price. Evidence for this calculation is medium.
Scenario range: $9.88 (bear) to $28.82 (bull), the price of $56.78 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
BrightSpring Health Services, Inc. Common Stock reported revenue of $12.9B in FY2025 versus $6.7B in FY2021, a compound +17.8%/yr. Reported net income was $191M in FY2025, compounding +39.9%/yr from FY2021.
Key figures
Market cap $12.5B · P/E ratio 73.7 · P/S ratio 1.09 · EPS (TTM) $0.7700 · Net margin 1.5% · Return on equity 9.2% · Return on assets (EBIT) 4.0% · Operating margin 3.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.
The share trades about 9% below its 52-week high and 199% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at −61%, BTSG screens richer than that median.
Fair Value models
Bear $9.88Fair Value $22.16Bull $28.82
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.5569 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.85/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+14.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.3%
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.2%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+34.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+34.5%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 3%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+25.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+12.5%
Yearly sales growth analysts expect, extended to five years.
News mood ⓘNews mood, the average tone of recent news (92 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
Compare BrightSpring Health Services, Inc. Common Stock with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 129 stocks
Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score42 · Below median
Fair Value upside−70% · Bottom 25%
Profitability
Return on equity (TTM)9% · Above median
Return on assets4% · Above median
Net margin (TTM)2% · Above median
Operating margin (TTM)3% · Below median
Growth and dividend
Revenue growth26% · Top 25%
Balance sheet
Debt / equity1.31× · Highest 25%
Valuation Multiplesvs Health Information Services median · lower = cheaper
P/E (TTM)73.7× · Priciest 25%
P/B7.13× · Priciest 25%
P/S (TTM)0.98× · Cheaper than median
P/FCF33.9× · Priciest 25%
EV/EBITDA28.5× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 35
PAST (return on equity)37· sector 6
HEALTH (low debt)35· sector 98
DIVIDEND (yield)0· sector 46
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "BrightSpring Health Services, Inc. Common Stock Fair Value". https://www.fairvalue-calculator.com/stock/BTSG
Frequently asked questions
Is BrightSpring Health Services, Inc. Common Stock (BTSG) overvalued or undervalued?
As of Sep 18, 2026, our model estimates a fair value of $22.16 versus a price of $56.78, about −61% upside (overvalued).
What is the fair value of BTSG?
Our model-based fair value for BrightSpring Health Services, Inc. Common Stock is $22.16 (as of Sep 18, 2026), built from audited fundamentals. The current price: $56.78.
What is the quality score of BTSG?
BrightSpring Health Services, Inc. Common Stock has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for BrightSpring Health Services, Inc. Common Stock (BTSG)?
Our model-based price target is the fair value of $22.16 (as of Sep 18, 2026) from 24 valuation models. Cautious scenario $9.88, optimistic scenario $28.82. It is a calculation from audited fundamentals, not an analyst target.
What is the BrightSpring Health Services, Inc. Common Stock stock forecast for 2026?
Our models put fair value at $22.16, about −61% upside versus a price of $56.78 (overvalued). Cautious scenario $9.88, optimistic scenario $28.82. The calculation is refreshed regularly with new filings.
What is the revenue of BrightSpring Health Services, Inc. Common Stock (BTSG)?
BrightSpring Health Services, Inc. Common Stock reported trailing-twelve-month revenue of about $13.6B (latest available figure, as of Sep 18, 2026).
What growth is priced into BrightSpring Health Services, Inc. Common Stock (BTSG)?
For today's price to be fair in a discounted-cash-flow model, BrightSpring Health Services, Inc. Common Stock would have to grow free cash flow by +25.2 % per year for five years (discount rate 11.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +18.3 % per year. As of Sep 18, 2026.
What discount rate (WACC) does the fair value of BTSG use?
Our models discount BrightSpring Health Services, Inc. Common Stock at 11.1 %: a base by market capitalisation (large), damped by beta 1.80, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For BrightSpring Health Services, Inc. Common Stock that is +25.2 % per year a year over ten years, using the same discount rate (11.1 %) and the same formula as our fair value.
How much growth has BrightSpring Health Services, Inc. Common Stock (BTSG) delivered so far?
Over the past 5 years revenue at BrightSpring Health Services, Inc. Common Stock grew +18.3 % a year. The price currently implies +25.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of BrightSpring Health Services, Inc. Common Stock (BTSG) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into BrightSpring Health Services, Inc. Common Stock (+25.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of BrightSpring Health Services, Inc. Common Stock (BTSG)?
The free-cash-flow yield on the price is 3.16 %: that much free cash flow BrightSpring Health Services, Inc. Common Stock produces per unit of market value. When it exceeds the discount rate of our models (11.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of BrightSpring Health Services, Inc. Common Stock (BTSG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For BrightSpring Health Services, Inc. Common Stock it is $22.16 per share (as of Sep 18, 2026), against a price of $56.78. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is BrightSpring Health Services, Inc. Common Stock stock overvalued or undervalued in 2026?
As of Sep 18, 2026, BTSG trades above its calculated fair value: price $56.78, fair value $22.16, a gap of about −61% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BTSG?
No. The price is what the market pays today ($56.78); the fair value is what the company's own numbers justify ($22.16). For BrightSpring Health Services, Inc. Common Stock the two are $34.62 per share apart. That gap is exactly why we show both numbers side by side.
How much is BrightSpring Health Services, Inc. Common Stock worth?
The market values BrightSpring Health Services, Inc. Common Stock at about $12.5B (market capitalisation, as of Sep 18, 2026). Per share that is $56.78; our models calculate a fair value of $22.16 per share.
What do the bullish and bearish scenarios say about BTSG?
Our models span a range for BrightSpring Health Services, Inc. Common Stock: cautious scenario $9.88, base $22.16, optimistic $28.82 per share (as of Sep 18, 2026, price $56.78). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BTSG?
BrightSpring Health Services, Inc. Common Stock trades at a price-to-earnings ratio of 73.7 (as of Sep 18, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $22.16 is built from several models across several years. Other multiples: P/B 7.1, P/S 1.0, EV/EBITDA 28.5.
How solid is the balance sheet of BrightSpring Health Services, Inc. Common Stock (BTSG)?
Balance-sheet figures for BrightSpring Health Services, Inc. Common Stock (as of Sep 18, 2026): return on equity 9.2%, debt of 1.31 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is BTSG from its 52-week high?
BrightSpring Health Services, Inc. Common Stock trades at $56.78, about 9% below its 52-week high of $62.11 and 199% above the low of $19.01 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $22.16 is for.
Which stocks are comparable to BrightSpring Health Services, Inc. Common Stock?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, HealthEquity, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is BrightSpring Health Services, Inc. Common Stock stock attractive at the current price?
The data as of Sep 18, 2026: price $56.78, calculated fair value $22.16 (−61%), Quality Score 42/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BTSG calculated?
We run BrightSpring Health Services, Inc. Common Stock through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $22.16, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 16.1 % above its aggregate fair value. BrightSpring Health Services, Inc. Common Stock itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of BrightSpring Health Services, Inc. Common Stock (BTSG)?
The closing price on Sep 18, 2026 was $56.78. Our model-based fair value is $22.16, about −61% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with BrightSpring Health Services, Inc. Common Stock right now?
The price sits above even our optimistic bull case ($28.82). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide ($9.88 to $28.82). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Key figures of BrightSpring Health Services, Inc. Common Stock
How large is the market capitalisation of BrightSpring Health Services, Inc. Common Stock (BTSG)?
The market capitalisation of BrightSpring Health Services, Inc. Common Stock is $12.5B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of BrightSpring Health Services, Inc. Common Stock (BTSG)?
The price-to-sales ratio of BrightSpring Health Services, Inc. Common Stock is 1.09 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of BrightSpring Health Services, Inc. Common Stock (BTSG)?
Earnings per share at BrightSpring Health Services, Inc. Common Stock are $0.7700 (price ÷ EPS = P/E 73.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of BrightSpring Health Services, Inc. Common Stock (BTSG)?
The net margin of BrightSpring Health Services, Inc. Common Stock is 1.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of BrightSpring Health Services, Inc. Common Stock (BTSG)?
The return on equity (ROE) of BrightSpring Health Services, Inc. Common Stock is 9.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of BrightSpring Health Services, Inc. Common Stock (BTSG)?
On an EBIT basis the return on assets of BrightSpring Health Services, Inc. Common Stock is 4.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of BrightSpring Health Services, Inc. Common Stock (BTSG)?
The operating margin of BrightSpring Health Services, Inc. Common Stock is 3.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at BrightSpring Health Services, Inc. Common Stock (BTSG)?
Revenue at BrightSpring Health Services, Inc. Common Stock is growing +25.6% versus a year earlier (3y avg +18.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at BrightSpring Health Services, Inc. Common Stock (BTSG)?
Earnings per share at BrightSpring Health Services, Inc. Common Stock are growing +360% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does BrightSpring Health Services, Inc. Common Stock (BTSG) carry?
The net debt of BrightSpring Health Services, Inc. Common Stock is $2.8B (fiscal year 2025, ≈ 7.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch BrightSpring Health Services, Inc. Common Stock in the live analysis
One click puts BrightSpring Health Services, Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Some data
Sep 18, 2026